Detail akcie GlycoMimetics online

Business Summary: GlycoMimetics, Inc. is a biotechnology company. The Company has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The Company was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, GlycoMimetics Inc revenues decreased from $10K to $0K. Net loss increased 3% to $37.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Identification and development of glycomimetic compounds segment loss increase of 2% to $40M.